98%
921
2 minutes
20
Background And Aims: Palliative radiotherapy practice patterns have been reported to vary widely, with a notable underutilization of single fraction treatment schedules. This study aims to investigate the outcomes and care patterns among patients receiving palliative radiotherapy for advanced cancer at a high-volume institution in Saudi Arabia.
Materials And Methods: Electronic records were used to identify patients receiving palliative radiotherapy for advanced cancer between 2018 and 2023. Univariate analyses were used to assess tumor and patient factors potentially associated with single fraction use, including primary tumor, target site, sex, age, admission status, and geographical remoteness from the center. Survival outcomes were analyzed using Kaplan-Meier curves.
Results: A total of 792 patients receiving 990 radiotherapy courses were identified. 60% of patients were female and 40% were male. The median age was 56.5 years (16.4 standard deviation [SD]). The most common primary histology was breast (34%), followed by gastrointestinal (13%). Single fraction treatment schedule represented 28.7% of all treatments and were most commonly used for extremities ( < 0.05). Multiple-fraction treatment schedule was more likely to be used for breast, chest, head-and-neck, pelvis, and spine < 0.05). The median survival was 6.9 months (SD = 8.9 months) and 25% of patients died within 30 days following radiotherapy. Median survival was shorter for male gender, admitted patients and those who did not complete their course of treatment (log-rank < 0.05).
Conclusion: Single fraction radiotherapy is underutilized in the management of advanced cancer patients, particularly those with bone metastases. Further research is warranted to develop clinical decision-making tools that enhance adherence to clinical guidelines and optimize treatment outcomes.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12411897 | PMC |
http://dx.doi.org/10.1089/pmr.2025.0008 | DOI Listing |
JCO Glob Oncol
May 2025
Department of Obstetrics and Gynaecology, Stanford University School of Medicine, Stanford, CA.
Purpose: Expanding high-risk human papillomavirus (HPV) vaccine coverage in resource-constrained settings is critical to bridging the cervical cancer gap and achieving the global action plan for elimination. Mobile health (mHealth) technology via short message services (SMS) has the potential to improve HPV vaccination uptake. The mHealth-HPVac study evaluated the effectiveness of mHealth interventions in increasing HPV vaccine uptake among mothers of unvaccinated girls aged 9-14 years in Lagos, Nigeria.
View Article and Find Full Text PDFPalliat Med Rep
April 2025
Department of Oncology, King Faisal Specialist Hospital & Research Centre (KFSH&RC), Jeddah, Saudi Arabia.
Background And Aims: Palliative radiotherapy practice patterns have been reported to vary widely, with a notable underutilization of single fraction treatment schedules. This study aims to investigate the outcomes and care patterns among patients receiving palliative radiotherapy for advanced cancer at a high-volume institution in Saudi Arabia.
Materials And Methods: Electronic records were used to identify patients receiving palliative radiotherapy for advanced cancer between 2018 and 2023.
Front Oncol
August 2025
Department of Radiotherapy, Nantong First People's Hospital (Affiliated Hospital 2 of Nantong University), Nantong, Jiangsu, China.
Purpose: Non-completion of radiotherapy courses (NCRC) may happen in patients undergoing intensity-modulated radiotherapy (IMRT). Analyzing the reasons and risk factors for NCRC can lead to possible targeted measures to reduce the incidence rate. This six-year retrospective study will present a cohort analysis of NCRC from a single center.
View Article and Find Full Text PDFCureus
August 2025
College of Health Sciences, Universidad San Francisco de Quito, Quito, ECU.
Lattice radiotherapy (LRT) is a type of spatially fractionated radiation therapy (SFRT) that enables the delivery of ablative doses to specific internal regions of large tumoral lesions, while surrounding tissues and nearby critical structures receive significantly lower exposure. This technique relies on a spatial distribution strategy that allows dose levels of radiation to be applied within the tumor in a single session or, alternatively, over the course of five sessions. Over time, LRT has gained attention as a promising method for managing large tumors, especially in cases where conventional treatments may pose higher risks or be less effective, offering the benefit of reduced side effects.
View Article and Find Full Text PDFCureus
August 2025
Internal Medicine, Chukwuemeka Odumegwu Ojukwu University Teaching Hospital, Awka, NGA.
Stage IV prostate cancer (PCa) refers to a disease that has metastasized beyond the prostate gland to distant sites, such as bones, visceral organs, or non-regional lymph nodes. While early attempts at curative therapy were occasionally made in oligometastatic cases, current guidelines uniformly recommend palliative-intent management once true metastatic spread is confirmed. Over the past decade, treatment paradigms have shifted from androgen deprivation therapy (ADT) monotherapy to earlier intensification with combination regimens including chemo-hormonal therapy and next-generation hormonal agents to improve survival and quality of life (QoL).
View Article and Find Full Text PDF